Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
5.71
-0.03 (-0.52%)
At close: Mar 9, 2026, 4:00 PM EDT
5.61
-0.10 (-1.75%)
After-hours: Mar 9, 2026, 5:53 PM EDT
Artiva Biotherapeutics Market Cap
Artiva Biotherapeutics has a market cap or net worth of $140.15 million as of March 9, 2026. Its market cap has increased by 53.05% in one year.
Market Cap
140.15M
Enterprise Value
28.87M
1-Year Change
53.05%
Ranking
Category
Stock Price
$5.71
Market Cap Chart
Since the IPO on July 19, 2024, Artiva Biotherapeutics's market cap has decreased from $176.76M to $140.15M, a decrease of -20.71%. That is a compound annual growth rate of -13.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 140.15M | 33.10% |
| Dec 31, 2025 | 105.30M | -56.99% |
| Dec 31, 2024 | 244.84M | 38.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 151.10M |
| Zentalis Pharmaceuticals | 148.60M |
| Corbus Pharmaceuticals Holdings | 148.41M |
| Unicycive Therapeutics | 141.63M |
| MacroGenics | 141.07M |
| Sangamo Therapeutics | 140.31M |
| Connect Biopharma Holdings | 138.64M |
| Adagene | 133.85M |